-
Discordance between Cystatin C-Based and Creatinine-Based Estimated Glomerular Filtration Rate and Mortality in the General Population Clin. Chem. (IF 7.1) Pub Date : 2025-06-04
Qiaoling Liu, Carlos Celis-Morales, Jennifer S Lees, Naveed Sattar, Frederick K Ho, Jill P Pell, Patrick B Mark, Paul WelshBackground The consequences for health outcomes of the discordance in cystatin C-based (eGFRcys) and creatinine-based (eGFRcr) estimated glomerular filtration rates are gaining attention. However, the association of discordance with all-cause mortality in the general population has not been explored. Methods A total of 325 356 UK Biobank participants, 40 to 69 years of age, were followed for a median
-
Identification of CD84 as a potent survival factor in acute myeloid leukemia J. Clin. Invest. (IF 13.3) Pub Date : 2025
Yinghui Zhu, Mariam Murtadha, Miaomiao Liu, Enrico Caserta, Ottavio Napolitano, Le Xuan Truong Nguyen, Huafeng Wang, Milad Moloudizargari, Lokesh Nigam, Theophilus Tandoh, Xuemei Wang, Alex Pozhitkov, Rui Su, Xiangjie Lin, Marc Denisse Estepa, Raju Pillai, Joo Song, James F. Sanchez, Yu-Hsuan Fu, Lianjun Zhang, Man Li, Bin Zhang, Ling Li, Ya-Huei Kuo, Steven Rosen, Guido Marcucci, John C. WilliamsAcute myeloid leukemia (AML) is an aggressive and often deadly malignancy associated with proliferative immature myeloid blasts. Here, we identified CD84 as a critical survival regulator in AML. High levels of CD84 expression provided a survival advantage to leukemia cells, whereas CD84 downregulation disrupted their proliferation, clonogenicity, and engraftment capabilities in both human cell lines
-
HINT1 aggravates aortic aneurysm by targeting ITGA6/FAK axis in vascular smooth muscle cells J. Clin. Invest. (IF 13.3) Pub Date : 2025
Yan Zhang, Wencheng Wu, Xuehui Yang, Shanshan Luo, Xiaoqian Wang, Qiang Da, Ke Yan, Lulu Hu, Shixiu Sun, Xiaolong Du, Xiaoqiang Li, Zhijian Han, Feng Chen, Aihua Gu, Liansheng Wang, Zhiren Zhang, Bo Yu, Chenghui Yan, Yaling Han, Yi Han, Liping Xie, Yong JiAortic aneurysm is a high-risk cardiovascular disease without an effective cure. Vascular smooth muscle cell (VSMC) phenotypic switching is a key step in the pathogenesis of aortic aneurysm. Here, we revealed the role of histidine triad nucleotide-binding protein 1 (HINT1) in aortic aneurysm. HINT1 was upregulated both in aortic tissue from patients with aortic aneurysm and angiotensin II–induced aortic
-
Deficiency of the Fanconi anemia core complex protein FAAP100 results in severe Fanconi anemia J. Clin. Invest. (IF 13.3) Pub Date : 2025
Benjamin A. Harrison, Emma Mizrahi-Powell, John Pappas, Kristen Thomas, Subrahmanya Vasishta, Shripad Hebbar, Anju Shukla, Shalini S. Nayak, Tina K. Truong, Amy Woroch, Yara Kharbutli, Bruce D. Gelb, Cassie S. Mintz, Gilad D. Evrony, Agata SmogorzewskaFanconi anemia (FA) is a rare genetic disease characterized by loss-of-function variants in any of the 22 previously identified genes (FANCA–FANCW) that encode proteins participating in the repair of DNA interstrand crosslinks (ICLs). Patient phenotypes are variable but may include developmental abnormalities, early-onset pancytopenia, and a predisposition to hematologic and solid tumors. Here, we
-
Genetic inactivation of FAAP100 causes Fanconi anemia due to disruption of the monoubiquitin ligase core complex J. Clin. Invest. (IF 13.3) Pub Date : 2025
Julia Kuehl, Yutong Xue, Fenghua Yuan, Ramanagouda Ramanagoudr-Bhojappa, Simone Pickel, Reinhard Kalb, Settara C. Chandrasekharappa, Weidong Wang, Yanbin Zhang, Detlev SchindlerThe Fanconi anemia/breast cancer (FA/BRCA) DNA repair network promotes the removal of DNA interstrand crosslinks (ICLs) to counteract their devastating consequences, including oncogenesis. Network signaling is initiated by the FA core complex, which consists of 7 authentic FA proteins and an FA-associated protein, FAAP100, with incompletely characterized roles and unknown disease associations. Upon
-
SOX9 suppresses colon cancer via inhibiting epithelial-mesenchymal transition and SOX2 induction J. Clin. Invest. (IF 13.3) Pub Date : 2025
Ying Feng, Ningxin Zhu, Karan Bedi, Jinju Li, Chamila Perera, Maranne Green, Naziheh Assarzadegan, Yali Zhai, Qingzhi Liu, Veerabhadran Baladandayuthapani, Jason R. Spence, Kathleen R. Cho, Eric R. FearonThe Wnt/β-catenin pathway regulates expression of the SOX9 gene, which encodes sex-determining region Y–box (SOX) transcription factor 9, a differentiation factor and potential β-catenin regulator. Because APC tumor suppressor defects in approximately 80% of colorectal cancers (CRCs) activate the Wnt/β-catenin pathway, we studied SOX9 inactivation in CRC biology. Compared with effects of Apc inactivation
-
Cxcr3 promotes protection from colorectal cancer liver metastasis by driving NK cell infiltration and plasticity J. Clin. Invest. (IF 13.3) Pub Date : 2025
Eleonora Russo, Chiara D’Aquino, Chiara Di Censo, Mattia Laffranchi, Luana Tomaipitinca, Valerio Licursi, Stefano Garofalo, Johann Promeuschel, Giovanna Peruzzi, Francesca Sozio, Anna Kaffke, Cecilia Garlanda, Ulf Panzer, Cristina Limatola, Christian A.J. Vosshenrich, Silvano Sozzani, Giuseppe Sciumè, Angela Santoni, Giovanni BernardiniThe antimetastatic activity of NK cells is well established in several cancer types, but the mechanisms underlying NK cell metastasis infiltration and acquisition of antitumor characteristics remain unclear. Herein, we investigated the cellular and molecular factors required to facilitate the generation of an ILC1-like CD49a+ NK cell population within the liver metastasis (LM) environment of colorectal
-
Preadipocyte IL-13/IL-13Rα1 signaling regulates beige adipogenesis through modulation of PPARγ activity J. Clin. Invest. (IF 13.3) Pub Date : 2025
Alexandra R. Yesian, Mayer M. Chalom, Nelson H. Knudsen, Alec L. Hyde, Jean Personnaz, Hyunjii Cho, Yae-Huei Liou, Kyle A. Starost, Chia-Wei Lee, Dong-Yan Tsai, Hsing-Wei Ho, Jr-Shiuan Lin, Jun Li, Frank B. Hu, Alexander S. Banks, Chih-Hao LeeType 2 innate lymphoid cells (ILC2s) regulate the proliferation of preadipocytes that give rise to beige adipocytes. Whether and how ILC2 downstream Th2 cytokines control beige adipogenesis remain unclear. We used cell systems and genetic models to examine the mechanism through which IL-13, an ILC2-derived Th2 cytokine, controls beige adipocyte differentiation. IL-13 priming in preadipocytes drove
-
4-1BB stimulation with concomitant inactivation of adenosine A2B receptors enhances CD8+ T cell antitumor response J. Clin. Invest. (IF 13.3) Pub Date : 2025
Jihae Ahn, Ping Xie, Siqi Chen, Guilan Shi, Jie Fan, Minghui Zhang, Hui Tang, Amanda R. Zuckerman, Deyu Fang, Yong Wan, Timothy M. Kuzel, Yi Zhang, Bin ZhangActivating the immune costimulatory receptor 4-1BB (CD137) with agonist antibody binding and crosslinking-inducing agents that elicit 4-1BB intracellular signaling potentiates the antitumor responses of CD8+ T cells. However, the underlying in-depth mechanisms remain to be defined. Here, we show that agonistic 4-1BB treatment of activated CD8+ T cells under continuous antigenic stimulation makes them
-
Immune repertoire profiling uncovers pervasive T cell clonal expansions in benign prostatic hyperplasia J. Clin. Invest. (IF 13.3) Pub Date : 2025
Anna S. Pollack, Christian A. Kunder, Chandler C. Ho, Josephine Chou, Andrew J. Pollack, Rachel L.P. Geisick, Bing M. Zhang, Robert B. West, James D. Brooks, Jonathan R. PollackTo the Editor: Benign prostatic hyperplasia (BPH) is the nodular proliferation of stromal and epithelial elements within the prostatic transition zone (surrounding the proximal urethra) that occurs in older men (1). BPH leads to prostate enlargement and lower urinary tract symptoms that range from bothersome (increased hesitancy, urgency, and frequency) to potentially life-threatening (infection, acute
-
Safety and implementation of phase I randomized GLA-SE–adjuvanted CH505TF gp120 HIV vaccine trial in newborns J. Clin. Invest. (IF 13.3) Pub Date : 2025
Avy Violari, Kennedy Otwombe, William Hahn, Shiyu Chen, Deirdre Josipovic, Vuyelwa Baba, Asimenia Angelidou, Kinga K. Smolen, Ofer Levy, Nonhlanhla N. Mkhize, Amanda S. Woodward Davis, Troy M. Martin, Barton F. Haynes, Wilton B. Williams, Zachary K. Sagawa, James G. Kublin, Laura Polakowski, Margaret Brewinski Isaacs, Catherine Yen, Georgia Tomaras, Lawrence Corey, Holly Janes, Glenda E. GrayBACKGROUND. The neonatal immune system is uniquely poised to generate broadly neutralizing antibodies (bnAbs), and thus infants are ideal for evaluating HIV vaccine candidates. We present the design and safety of a new-in-infants glucopyranosyl lipid A–stable emulsion (GLA-SE) adjuvant admixed with a first-in-infant CH505 transmitter-founder (CH505TF) gp120 immunogen designed to induce precursors for
-
Transcriptomic profiling after B cell depletion reveals central and peripheral immune cell changes in multiple sclerosis J. Clin. Invest. (IF 13.3) Pub Date : 2025
Jessica Wei, Jeonghyeon Moon, Yoshiaki Yasumizu, Le Zhang, Khadir Radassi, Nicholas Buitrago-Pocasangre, M. Elizabeth Deerhake, Nicolas Strauli, Chun-Wei Chen, Ann Herman, Rosetta Pedotti, Catarina Raposo, Isaiah Yim, Jenna Pappalardo, Erin E. Longbrake, Tomokazu S. Sumida, Pierre-Paul Axisa, David A. HaflerMultiple sclerosis (MS) is a complex, genetically mediated autoimmune disease of the CNS, in which anti-CD20–mediated B cell depletion is remarkably effective in the treatment of early disease. Although previous studies investigated the effect of B cell depletion on select immune cell subsets using flow cytometry–based methods, the therapeutic effect on the patient’s immune landscape is unknown. In
-
Hyaluronan network remodeling by ZEB1 and ITIH2 enhances the motility and invasiveness of cancer cells J. Clin. Invest. (IF 13.3) Pub Date : 2025
Sieun Lee, Jihye Park, Seongran Cho, Eun Ju Kim, Seonyeong Oh, Younseo Lee, Sungsoo Park, Keunsoo Kang, Dong Hoon Shin, Song Yi Ko, Jonathan M. Kurie, Young-Ho AhnHyaluronan (HA) in the extracellular matrix promotes epithelial-mesenchymal transition (EMT) and metastasis; however, the mechanism by which the HA network constructed by cancer cells regulates cancer progression and metastasis in the tumor microenvironment (TME) remains largely unknown. In this study, inter-α-trypsin inhibitor heavy chain 2 (ITIH2), an HA-binding protein, was confirmed to be secreted
-
Gut microbial metabolite 4-hydroxybenzeneacetic acid drives colorectal cancer progression via accumulation of immunosuppressive PMN-MDSCs J. Clin. Invest. (IF 13.3) Pub Date : 2025
Qing Liao, Ximing Zhou, Ling Wu, Yuyi Yang, Xiaohui Zhu, Hangyu Liao, Yujie Zhang, Weidong Lian, Feifei Zhang, Hui Wang, Yanqing Ding, Liang ZhaoColorectal cancer (CRC) is characterized by an immune-suppressive microenvironment that contributes to tumor progression and immunotherapy resistance. The gut microbiome produces diverse metabolites that feature unique mechanisms of interaction with host targets, yet the role of many metabolites in CRC remains poorly understood. In this study, the microbial metabolite 4-hydroxybenzeneacetic acid (4-HPA)
-
Robotic Process Automation in Laboratory Medicine. Clin. Chem. (IF 7.1) Pub Date : 2025-05-28
Khushbu Patel,Simone Arvisais-Anhalt,Dustin R Bunch,Daniel T Holmes,Nicholas C Spies -
Splicing of erythroid transcription factor is associated with therapeutic response in myelodysplastic syndromes. J. Clin. Invest. (IF 13.3) Pub Date : 2025-05-27
Srinivas Aluri,Te Ling,Ellen Fraint,Samarpana Chakraborty,Kevin Zhang,Aarif Ahsan,Leah Kravets,Gowri Poigaialwar,Rongbao Zhao,Kith Pradhan,Anitria Cotton,Kimo Bachiashvili,Jung-In Yang,Anjali Budhathoki,Beamon Agarwal,Shanisha Gordon-Mitchell,Milagros Carbajal,Srabani Sahu,Jacqueline Boultwood,Andrea Pellagatti,Ulrich Steidl,Amittha Wickrema,Satish Nandakumar,Aditi Shastri,Rajasekhar Nvs Suragani,TeresaAnemia is the primary clinical manifestation of myelodysplastic syndromes (MDS), but the molecular pathogenesis of ineffective erythropoiesis remains incompletely understood. Luspatercept, an activin receptor 2B (ACVRIIB-Fc) ligand trap, has been approved to treat anemia, however its molecular mechanism of action is unclear. We found that the ACVR2B, its ligand GDF11, and effector, SMAD2, are upregulated
-
Diagnosis of Drug-Resistant Tuberculosis: Rapid Evaluation of Drug Susceptibility with Nanopore Targeted Sequencing. Clin. Chem. (IF 7.1) Pub Date : 2025-05-27
Jun Chen,Qijing Fan,Shiwei Gong,Jianjian Guo,Youyi Rao,Lifeng Chen,Ying Wang,Rui Liao,Zhengbin Zhang,Chang Liu,Ming Wu,Shi Chen,Yi RenBACKGROUND Whole-genome sequencing (WGS) has limitations in clinical diagnostics due to host DNA interference and lower pathogen load in clinical samples compared to cultured isolates, which reduce the effective sequencing depth and compromise the detection of resistance-associated mutations. As our understanding of the relationship between genotypes and phenotypes improves, targeted next-generation
-
Reducing the Noise in Plasma Metagenomics to Further Define Clinical Utility. Clin. Chem. (IF 7.1) Pub Date : 2025-05-26
Jennifer M Bosquez,Erin H Graf -
Full-Length Clonal Immunoglobulin Rearrangements in cfDNA: Improved Recovery and Sequencing Clin. Chem. (IF 7.1) Pub Date : 2025-05-26
Rena R Xian, Prisca Mbonu, Lisa M Haley, Troy Billson, Kevin He, Emily Adams, Ming-Tseh Lin, Moosa Patel, Atul Lakha, Garrick Laudin, Tanvier Omar, Philippa Ashmore, Sugeshnee Pather, Elizabeth Mayne, Wendy Stevens, Vinitha Philip, Christopher D Gocke, Neil A Martinson, Samantha L Vogt, Richard F AmbinderBackground Circulating tumor DNA present in cell-free DNA (cfDNA) serves as diagnostic, predictive, and prognostic markers in cancer patients. In lymphoma patients, clonal immunoglobulin (cIg) sequences enable accurate identification of disease states. Despite its importance, there is sparse literature surrounding the preanalytical and analytical conditions that affect cIg detection in cfDNA. This
-
Challenges in Hb A1c Point-of-Care Testing: Only 6 of 19 Hb A1c Point-of-Care Devices Meet IFCC and NGSP Certification Criteria on Independent Evaluation Clin. Chem. (IF 7.1) Pub Date : 2025-05-26
Erna Lenters-Westra, Priyanka Singh, Beatrice Vetter, Emma EnglishBackground Access to Hb A1c testing in low- and middle-income countries (LMICs) can be limited, especially in rural areas. This has led to an increased interest in the potential role of point-of-care testing (POCT) for Hb A1c. The analytical performance of many of these devices is poorly understood but accurate and precise measurement is essential for effective diabetes management. Methods Verification
-
Chemotaxis overrides killing response in alloreactive cytotoxic T-cells providing vascular immune privilege during cellular rejection. J. Clin. Invest. (IF 13.3) Pub Date : 2025-05-22
T Barba,M Oberbarnscheidt,G Franck,C Gao,S This,M Rabeyrin,C Roufosse,L Moran,A Koenig,V Mathias,C Saison,V Dubois,N Pallet,D Anglicheau,B Lamarthée,A Hertig,E Morelon,A Hot,H Paidassi,T Defrance,A Nicoletti,J P Duong-Van-Huyen,Y Xu-Dubois,F G Lakkis,O ThaunatGraft endothelial cells (ECs) express donor alloantigens and encounter cytotoxic T lymphocytes (CTLs) but are generally spared during T cell-mediated rejection (TCMR), which predominantly affects epithelial structures. The mechanisms underlying this vascular immune privilege are unclear. Transcriptomic analyses and endothelial-mesenchymal transition assessments confirmed that the graft endothelium
-
Myeloid cell genome-wide screen identifies variants associated with Mycobacterium tuberculosis-induced cytokine transcriptional responses. J. Clin. Invest. (IF 13.3) Pub Date : 2025-05-22
Joshua J Ivie,Kimberly A Dill-McFarland,Jason D Simmons,Glenna J Peterson,Penelope H Benchek,Harriet Mayanja-Kizza,Lily E Veith,Moeko Agata,Dang Tm Ha,Ho Dt Nghia,W Henry Boom,Catherine M Stein,Chiea C Khor,Guy E Thwaites,Hoang T Hai,Nguyen Tt Thuong,Xuling Chang,Sarah J Dunstan,Thomas R HawnImmune and clinical outcomes to Mycobacterium tuberculosis (Mtb) infection vary greatly between individuals yet the underlying genetic and cellular mechanisms driving this heterogeneity remain poorly understood. We performed a cellular genome-wide association study (GWAS) to identify genetic variants associated with Mtb-induced monocyte transcriptional expression of IL1B, IL6, TNF, and IFNB1 via RNA-seq
-
Plasma Neprilysin in Heart Failure: Response Dynamics and Clinical Associations Are Immunoassay Dependent Clin. Chem. (IF 7.1) Pub Date : 2025-05-21
Samantha S M Ling, Shera Lilyanna, Jenny P C Chong, Jessica Y X Ng, Siew-Pang Chan, Timothy C R Prickett, Lee Lee Wong, A Mark Richards, Oi Wah LiewBackground Discordance among published findings on the plasma concentrations, response dynamics, and clinical associations of plasma neprilysin (NEP) in health and heart failure (HF) require clarification. Method Using a newly developed glycosylation-sensitive monoclonal antibody sandwich ELISA (NEPCVRI), plasma NEP was measured in 99 non-HF controls, 95 HF patients with preserved ejection fraction
-
Trapα deficiency impairs the early events of insulin biosynthesis and glucose homeostasis. J. Clin. Invest. (IF 13.3) Pub Date : 2025-05-20
Xin Li,Jingxin Hu,Yumeng Huang,Hai Zhang,Ning Xu,Yang Liu,Xuan Liu,Yuanyuan Ye,Xinxin Zhang,Xiaoxi Xu,Yuxin Fan,Ziyue Zhang,Weiping J Zhang,Shusen Wang,Wenli Feng,Peter Arvan,Ming LiuDefects in the early events of insulin biosynthesis, including inefficient preproinsulin (PPI) translocation across the membrane of the endoplasmic reticulum (ER) and proinsulin (PI) misfolding in the ER, can cause diabetes. Cellular machineries involved in these events remain poorly defined. Gene encoding TRanslocon-Associated Protein alpha (TRAPα) shows linkage to glycemic control in humans, although
-
Integrin-mediated mTOR signaling drives TGF-β overactivity and myxomatous mitral valve degeneration in hypomorphic fibrillin-1 mice. J. Clin. Invest. (IF 13.3) Pub Date : 2025-05-20
Fu Gao,Qixin Chen,Makoto Mori,Sufang Li,Giovanni Ferrari,Markus Krane,Rong Fan,George Tellides,Yang Liu,Arnar GeirssonMitral valve prolapse is often benign but progression to mitral regurgitation may require invasive intervention and there is no specific medical therapy. An association of mitral valve prolapse with Marfan syndrome resulting from pathogenic FBN1 variants supports the use of hypomorphic fibrillin-1 mgR mice to investigate mechanisms and therapy for mitral valve disease. mgR mice developed severe myxomatous
-
Bacterial vaginosis associates with dysfunctional T cells and altered soluble immune factors in the cervicovaginal tract J. Clin. Invest. (IF 13.3) Pub Date : 2025
Finn MacLean, Adino Tesfahun Tsegaye, Jessica B. Graham, Jessica L. Swarts, Sarah C. Vick, Nicole B. Potchen, Irene Cruz Talavera, Lakshmi Warrier, Julien Dubrulle, Lena K. Schroeder, Ayumi Saito, Corinne Mar, Katherine K. Thomas, Matthias Mack, Michelle C. Sabo, Bhavna H. Chohan, Kenneth Ngure, Nelly Rwamba Mugo, Jairam R. Lingappa, Jennifer M. Lund, for the Kinga Study TeamBACKGROUND. Bacterial vaginosis (BV) is a dysbiosis of the vaginal microbiome that is prevalent among reproductive-age females worldwide. Adverse health outcomes associated with BV include an increased risk of sexually acquired HIV, yet the immunological mechanisms underlying this association are not well understood.
-
Maintenance of graft tissue–resident Foxp3+ cells is necessary for lung transplant tolerance in mice J. Clin. Invest. (IF 13.3) Pub Date : 2025
Wenjun Li, Yuriko Terada, Yun Zhu Bai, Yuhei Yokoyama, Hailey M. Shepherd, Junedh M. Amrute, Amit I. Bery, Zhiyi Liu, Jason M. Gauthier, Marina Terekhova, Ankit Bharat, Jon H. Ritter, Varun Puri, Ramsey R. Hachem, Hēth R. Turnquist, Peter T. Sage, Alessandro Alessandrini, Maxim N. Artyomov, Kory J. Lavine, Ruben G. Nava, Alexander S. Krupnick, Andrew E. Gelman, Daniel KreiselMechanisms that mediate allograft tolerance differ between organs. We have previously shown that Foxp3+ T cell–enriched bronchus-associated lymphoid tissue (BALT) is induced in tolerant murine lung allografts and that these Foxp3+ cells suppress alloimmune responses locally and systemically. Here, we demonstrated that Foxp3+ cells that reside in tolerant lung allografts differed phenotypically and
-
Erythrocyte-derived extracellular vesicles induce endothelial dysfunction through arginase-1 and oxidative stress in type 2 diabetes J. Clin. Invest. (IF 13.3) Pub Date : 2025
Aida Collado, Rawan Humoud, Eftychia Kontidou, Maria Eldh, Jasmin Swaich, Allan Zhao, Jiangning Yang, Tong Jiao, Elena Domingo, Emelie Carlestål, Ali Mahdi, John Tengbom, Ákos Végvári, Qiaolin Deng, Michael Alvarsson, Susanne Gabrielsson, Per Eriksson, Zhichao Zhou, John PernowRed blood cells (RBCs) induce endothelial dysfunction in type 2 diabetes (T2D), but the mechanism by which RBCs communicate with the endothelium is unknown. This study tested the hypothesis that extracellular vesicles (EVs) secreted by RBCs act as mediators of endothelial dysfunction in T2D. Despite a lower production of EVs derived from RBCs of T2D patients (T2D RBC-EVs), their uptake by endothelial
-
Inhibition of DNAJ-HSP70 interaction improves strength in muscular dystrophy J. Clin. Invest. (IF 13.3) Pub Date : 2025
Rocio Bengoechea, Andrew R. Findlay, Ankan K. Bhadra, Hao Shao, Kevin C. Stein, Sara K. Pittman, Jil A.W. Daw, Jason E. Gestwicki, Heather L. True, Conrad C. WeihlInhibition of DNAJ-HSP70 interaction improves strength in muscular dystrophy Rocio Bengoechea, … , Heather L. True, Conrad C. Weihl Rocio Bengoechea, … , Heather L. True, Conrad C. Weihl Research Article Cell biology Muscle biology
-
Endothelial dysfunction in patients with type 2 diabetes: the truth is in the blood J. Clin. Invest. (IF 13.3) Pub Date : 2025
Sarah Costantino, Shafeeq A. Mohammed, Francesco PaneniEndothelial dysfunction remains a cornerstone of diabetic vascular complications. RBCs emerge as pivotal players in endothelial dysfunction, yet the underlying mechanisms remain elusive. In this issue of the JCI, Collado et al. show that the detrimental action of RBCs on the endothelium is mediated by extracellular vesicles (EVs). EVs derived from RBCs (RBC-EVs) of patients with diabetes were taken
-
Disease classification, diagnostic challenges, and evolving clinical trial design in MASLD J. Clin. Invest. (IF 13.3) Pub Date : 2025
Mette Munk Lauridsen, Kim Ravnskjaer, Lise Lotte Gluud, Arun J. SanyalMetabolic dysfunction–associated steatotic liver disease (MASLD) diagnosis and management have evolved rapidly alongside the increasing prevalence of obesity and related complications. Hepatology has expanded its focus beyond late-stage cirrhosis and portal hypertension to earlier, complex MASLD cases in younger patients, necessitating closer collaboration with endocrinology. The renaming of nonalcoholic
-
Induced clustering of SHP2-depleted tumor cells in vascular islands restores sensitivity to MEK/ERK inhibition J. Clin. Invest. (IF 13.3) Pub Date : 2025
Yuyi Wang, Hidetaka Ohnuki, Andy D. Tran, Dunrui Wang, Taekyu Ha, Jing-Xin Feng, Minji Sim, Raymond Barnhill, Claire Lugassy, Michael R. Sargen, Emanuel Salazar-Cavazos, Michael Kruhlak, Giovanna TosatoAllosteric inhibitors of the tyrosine phosphatase Src homology 2 domain–containing protein tyrosine phosphatase 2 (SHP2) hold therapeutic promise in cancers with overactive RAS/ERK signaling, but adaptive resistance to SHP2 inhibitors may limit benefits. Here, we utilized tumor cells that proliferate similarly with or without endogenous SHP2 to explore means to overcome this growth independence from
-
Reactivation of CTLA4-expressing T cells accelerates resolution of lung fibrosis in a humanized mouse model J. Clin. Invest. (IF 13.3) Pub Date : 2025
Santosh Yadav, Muralidharan Anbalagan, Shamima Khatun, Devadharshini Prabhakaran, Yasuka Matsunaga, Justin Manges, James B. McLachlan, Joseph A. Lasky, Jay Kolls, Victor J. ThannickalTissue regenerative responses involve complex interactions between resident structural and immune cells. Recent reports indicate that accumulation of senescent cells during injury repair contributes to pathological tissue fibrosis. Using tissue-based spatial transcriptomics and proteomics, we identified upregulation of the immune checkpoint protein, cytotoxic T lymphocyte–associated protein 4 (CTLA4)
-
Disrupted minor intron splicing activates reductive carboxylation-mediated lipogenesis to drive metabolic dysfunction–associated steatotic liver disease progression J. Clin. Invest. (IF 13.3) Pub Date : 2025
Yinkun Fu, Xin Peng, Hongyong Song, Xiaoyun Li, Yang Zhi, Jieting Tang, Yifan Liu, Ding Chen, Wenyan Li, Jing Zhang, Jing Ma, Ming He, Yimin Mao, Xu-Yun ZhaoAberrant RNA splicing is tightly linked to diseases, including metabolic dysfunction–associated steatotic liver disease (MASLD). In this study, we revealed that minor intron splicing, a unique and conserved RNA processing event, is largely disrupted upon the progression of metabolic dysfunction–associated steatohepatitis (MASH) in mice and humans. We demonstrated that deficiency of minor intron splicing
-
EGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulates AKT-promoted tumorigenesis J. Clin. Invest. (IF 13.3) Pub Date : 2025
Haizhong Feng, Giselle Y. Lopez, Chung Kwon Kim, Angel Alvarez, Christopher G. Duncan, Ryo Nishikawa, Motoo Nagane, An-Jey A. Su, Philip E. Auron, Matthew L. Hedberg, Lin Wang, Jeffery J. Raizer, John A. Kessler, Andrew T. Parsa, Wei-Qiang Gao, Sung-Hak Kim, Mutsuko Minata, Ichiro Nakano, Jennifer R. Grandis, Roger E. McLendon, Darell D. Bigner, Hui-Kuan Lin, Frank B. Furnari, Webster K. Cavenee, BoEGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulates AKT-promoted tumorigenesis Haizhong Feng, … , Hai Yan, Shi-Yuan Cheng Haizhong Feng, … , Hai Yan, Shi-Yuan Cheng Research Article Oncology
-
Mutant prion protein enhances NMDA receptor activity, activates PKC, and triggers rapid excitotoxicity in mice J. Clin. Invest. (IF 13.3) Pub Date : 2025
Joie Lin, Julia A. Callender, Joshua E. Mayfield, Daniel B. McClatchy, Daniel Ojeda-Juárez, Mahsa Pourhamzeh, Katrin Soldau, Timothy D. Kurt, Garrett A. Danque, Helen Khuu, Josephina E. Ronson, Donald P. Pizzo, Yixing Du, Maxwell A. Gruber, Alejandro M. Sevillano, Jin Wang, Christina D. Orrú, Joy Chen, Gail Funk, Patricia Aguilar-Calvo, Brent D. Aulston, Subhojit Roy, Jong M. Rho, Jack D. Bui, AlexandraNeuronal hyperexcitability precedes synapse loss in certain neurodegenerative diseases, yet the synaptic membrane interactions and downstream signaling events remain unclear. The disordered amino terminus of the prion protein (PrPC) has been implicated in aberrant signaling in prion and Alzheimer’s disease. To disrupt neuronal interactions and signaling linked to the amino terminus, we CRISPR-engineered
-
GALNT14 deficiency: connecting multiple links in the IgA nephropathy pathogenetic chain J. Clin. Invest. (IF 13.3) Pub Date : 2025
John Pell, Madhav C. MenonIgA nephropathy (IgAN) is a highly prevalent type of primary glomerulonephritis. IgAN involves mesangial deposition of immune complexes leading to complement activation, inflammation, and glomerular injury. A key hit for pathogenesis involves aberrant O-glycosylation in the hinge region of IgA. Despite its prevalence, however, the mechanisms underlying IgAN remain incompletely understood. In this issue
-
Absence of the intracellular lipolytic inhibitor G0S2 enhances intravascular triglyceride clearance and abolishes diet-induced hypertriglyceridemia J. Clin. Invest. (IF 13.3) Pub Date : 2025
Yongbin Chen, Scott M. Johnson, Stephanie D. Burr, Davide Povero, Aaron M. Anderson, Cailin E. McMahon, Jun LiuThe interplay between intracellular and intravascular lipolysis is crucial for maintaining circulating lipid levels and systemic energy homeostasis. Adipose triglyceride lipase (ATGL) and lipoprotein lipase (LPL), the primary triglyceride (TG) lipases responsible for these two spatially separate processes, are highly expressed in adipose tissue. Yet the mechanisms underlying their coordinated regulation
-
IL-32–producing CD8+ memory T cells define immunoregulatory niches in human cutaneous leishmaniasis J. Clin. Invest. (IF 13.3) Pub Date : 2025
Nidhi S. Dey, Shoumit Dey, Naj Brown, Sujai Senarathne, Luiza Campos Reis, Ritika Sengupta, Jose A.L. Lindoso, Sally R. James, Lesley Gilbert, Dave Boucher, Mitali Chatterjee, Hiro Goto, Shalindra Ranasinghe, Paul M. KayeHuman cutaneous leishmaniasis (CL) is characterized by chronic skin pathology. Experimental and clinical data suggest that immune checkpoints (ICs) play a crucial role in disease outcome, but the cellular and molecular niches that facilitate IC molecule expression during leishmaniasis are ill defined. In Sri Lankan patients with CL, indoleamine 2,3-dioxygenase 1 (IDO1) and programmed death–ligand 1
-
TMEM219 signaling promotes intestinal stem cell death and exacerbates colitis J. Clin. Invest. (IF 13.3) Pub Date : 2025
Francesca D’Addio, Giovanni Amabile, Emma Assi, Anna Maestroni, Adriana Petrazzuolo, Cristian Loretelli, Ahmed Abdelasalam, Moufida Ben Nasr, Ida Pastore, Maria Elena Lunati, Vera Usuelli, Monica Zocchi, Andy Joe Seelam, Domenico Corradi, Stefano La Rosa, Virna Marin, Monique Zangarini, Marta Nardini, Stefano Porzio, Filippo Canducci, Claudia Nardini, Basset El Essawy, Manuela Nebuloni, Jun Yang, MassimoMechanisms by which mucosal regeneration is abrogated in inflammatory bowel disease (IBD) are still under investigation, and a role for an intestinal stem cell (ISC) defect is now emerging. Herein, we report an abnormal ISC death that occurs in Crohn’s disease, which exacerbates colitis, limits ISC-dependent mucosal repair, and is controlled through the death factor Transmembrane protein 219 (TMEM219)
-
Traffic jam in lung capillaries: inter-organ communication impedes gas exchange after acute kidney injury J. Clin. Invest. (IF 13.3) Pub Date : 2025
Ulrich Matt, Susanne HeroldAcute kidney injury (AKI) is a frequent complication in critically ill patients and triggers a systemic inflammatory response that can contribute to lung injury, ultimately worsening clinical outcomes. However, diagnostic and therapeutic strategies remain unavailable. In this issue of the JCI, Komaru et al. explored leukocyte trafficking and vascular pooling following AKI in mice as an underlying mechanism
-
Promoting mucosal healing by targeting TMEM219-dependent intestinal epithelial stem cell defects in inflammatory bowel disease J. Clin. Invest. (IF 13.3) Pub Date : 2025
Nicolas SchlegelInflammatory Bowel Diseases (IBD), including Crohn’s disease and ulcerative colitis, pose challenges due to their complex pathophysiology and high prevalence. Despite advances in immune-targeted therapies, a substantial number of patients fail to achieve mucosal healing, highlighting the need for alternative therapeutic strategies. In this issue of the JCI, D’Addio et al. identified another mechanism
-
Metabolic dysfunction–associated steatotic liver disease and pregnancy J. Clin. Invest. (IF 13.3) Pub Date : 2025
Monika Sarkar, Tatyana KushnerMetabolic dysfunction–associated steatotic liver disease (MASLD) is rising among reproductive-aged individuals and in pregnancy. MASLD in pregnancy does increase such risks as gestational diabetes, preeclampsia, and preterm birth. Although routine screening for MASLD has not been established in pregnancy, individuals with metabolic comorbidities, such as type 2 diabetes mellitus, should be evaluated
-
Clemastine fumarate accelerates accumulation of disability in progressive multiple sclerosis by enhancing pyroptosis J. Clin. Invest. (IF 13.3) Pub Date : 2025
Joanna Kocot, Peter Kosa, Shinji Ashida, Nicolette A. Pirjanian, Raphaela Goldbach-Mansky, Karin Peterson, Valentina Fossati, Steven M. Holland, Bibiana BielekovaMultiple sclerosis (MS) is an immune-mediated demyelinating disease of the CNS. Clemastine fumarate, the over-the-counter antihistamine and muscarinic receptor blocker, has remyelinating potential in MS. A clemastine arm was added to an ongoing platform clinical trial, targeting residual activity by precision, biomarker-guided combination therapies of multiple sclerosis (TRAP-MS) (ClinicalTrials.gov
-
Loss of GalNAc-T14 links O-glycosylation defects to alterations in B cell homing in IgA nephropathy J. Clin. Invest. (IF 13.3) Pub Date : 2025
Sindhuri Prakash, Nicholas J. Steers, Yifu Li, Elena Sanchez-Rodriguez, Miguel Verbitsky, Isabel Robbins, Jenna Simpson, Sharvari Pathak, Milan Raska, Colin Reily, Anna Ng, Judy Liang, Natalia DeMaria, Amanda Katiraei, Kelsey O. Stevens, Clara Fischman, Samantha Shapiro, Swetha Kodali, Jason McCutchan, Heekuk Park, Djamila Eliby, Marco Delsante, Landino Allegri, Enrico Fiaccadori, Monica Bodria, MaddalenaAberrant O-glycosylation of the IgA1 hinge region is a characteristic finding in patients with IgA nephropathy (IgAN) and is thought to contribute to immune-complex formation and kidney injury. Other studies have suggested that abnormalities in mucosal immunity and lymphocyte homing are major contributors to disease. We identified a family with IgAN segregating a heterozygous predicted loss-of-function
-
TP53 mutations and TET2 deficiency cooperate to drive leukemogenesis and establish an immunosuppressive environment J. Clin. Invest. (IF 13.3) Pub Date : 2025
Pu Zhang, Ethan C. Whipp, Sarah J. Skuli, Mehdi Gharghabi, Caner Saygin, Steven A. Sher, Martin Carroll, Xiangyu Pan, Eric D. Eisenmann, Tzung-Huei Lai, Bonnie K. Harrington, Wing Keung Chan, Youssef Youssef, Bingyi Chen, Alex Penson, Alexander M. Lewis, Cynthia R. Castro, Nina Fox, Ali Cihan, Jean-Benoit Le Luduec, Susan DeWolf, Tierney Kauffman, Alice S. Mims, Daniel Canfield, Hannah Phillips, KatieMutations and deletions in TP53 are associated with adverse outcomes in patients with myeloid malignancies, and there is an urgent need for the development of improved therapies for TP53-mutant leukemias. Here, we identified mutations in TET2 as the most common co-occurring mutation in patients with TP53-mutant acute myeloid leukemia (AML). In mice, combined hematopoietic-specific deletion of TET2
-
AgRP neuron hyperactivity drives hyperglycemia in a mouse model of type 2 diabetes J. Clin. Invest. (IF 13.3) Pub Date : 2025
Yang Gou, Micaela Glat, Vincent Damian, Caeley L. Bryan, Bao Anh Phan, Chelsea L. Faber, Arikta Trivedi, Matthew K. Hwang, Jarrad M. Scarlett, Gregory J. Morton, Michael W. SchwartzGrowing evidence suggests that the pathogenesis of type 2 diabetes (T2D) involves dysfunctional central mechanisms, and, hence, the brain can be targeted to treat this disease. As an example, a single intracerebroventricular (icv) injection of fibroblast growth factor 1 (FGF1) can normalize hyperglycemia for weeks or months in rodent models of T2D. Convergent evidence implicates inhibition of a particular
-
Targeting legumain-mediated cell-cell interaction sensitizes glioblastoma to immunotherapy in preclinical models J. Clin. Invest. (IF 13.3) Pub Date : 2025
Lizhi Pang, Songlin Guo, Yuyun Huang, Fatima Khan, Yang Liu, Fei Zhou, Justin D. Lathia, Peiwen ChenTumor-associated macrophages (TAMs) are the most prominent immune cell population in the glioblastoma (GBM) tumor microenvironment and play critical roles in promoting tumor progression and immunosuppression. Here we identified that TAM-derived legumain (LGMN) exhibited a dual role in regulating the biology of TAMs and GBM cells. LGMN promoted macrophage infiltration in a cell-autonomous manner by
-
ST6GalNAc-I regulates tumor cell sialylation via NECTIN2/MUC5AC-mediated immunosuppression and angiogenesis in non–small cell lung cancer J. Clin. Invest. (IF 13.3) Pub Date : 2025
Muthamil Iniyan Appadurai, Sanjib Chaudhary, Ashu Shah, Gopalakrishnan Natarajan, Zahraa W. Alsafwani, Parvez Khan, Dhananjay D. Shinde, Subodh M. Lele, Lynette M. Smith, Mohd Wasim Nasser, Surinder Kumar Batra, Apar Kishor Ganti, Imayavaramban LakshmananGlycosylation controls immune evasion, tumor progression, and metastasis. However, how tumor cell sialylation regulates immune evasion remains poorly characterized. ST6GalNAc-I, a sialyltransferase that conjugates sialic acid to the glycans in glycoproteins, was overexpressed in an aggressive-type KPA (KrasG12D/+ Trp53R172H/+ Ad-Cre) lung adenocarcinoma (LUAD) model and patient samples. Proteomic and
-
Ubiquitin-conjugating enzyme UBE2N modulates proteostasis in immunoproteasome-positive acute myeloid leukemia J. Clin. Invest. (IF 13.3) Pub Date : 2025
Chiharu Ishikawa, Laura Barreyro, Avery M. Sampson, Kathleen M. Hueneman, Kwangmin Choi, Sophia Y. Philbrook, Issac Choi, Lyndsey C. Bolanos, Mark Wunderlich, Andrew G. Volk, Stephanie S. Watowich, Kenneth D. Greis, Daniel T. StarczynowskiAltered protein homeostasis through proteasomal degradation of ubiquitinated proteins is a hallmark of many cancers. Ubiquitination, coordinated by E1, E2, and E3 enzymes, involves up to 40 E2-conjugating enzymes in humans to specify substrates and ubiquitin linkages. In a screen for E2 dependencies in acute myeloid leukemia (AML), ubiquitin conjugating enzyme E2 N (UBE2N) emerged as the top candidate
-
Gene-environment interaction modifies the association between hyperinsulinemia and serum urate levels through SLC22A12 J. Clin. Invest. (IF 13.3) Pub Date : 2025
Wataru Fujii, Osamu Yamazaki, Daigoro Hirohama, Ken Kaseda, Emiko Kuribayashi-Okuma, Motonori Tsuji, Makoto Hosoyamada, Yuta Kochi, Shigeru ShibataBACKGROUND. Hyperinsulinemia and insulin resistance often accompany elevated serum urate levels (hyperuricemia), a highly heritable condition that triggers gout; however, the underlying mechanisms are unclear.
-
Asparagine endopeptidase cleaves apolipoprotein A1 and accelerates pathogenesis of atherosclerosis J. Clin. Invest. (IF 13.3) Pub Date : 2025
Mengmeng Wang, Bowei Li, Shuke Nie, Xin Meng, Guangxing Wang, Menghan Yang, Wenxin Dang, Kangning He, Tucheng Sun, Ping Xu, Xifei Yang, Keqiang YeAtherosclerosis is a slowly progressing inflammatory disease characterized with cholesterol disorder and intimal plaques. Asparagine endopeptidase (AEP) is an endolysosomal protease that is activated under acidic conditions and is elevated substantially in both plasma and plaques of patients with atherosclerosis. However, how AEP accelerates atherosclerosis development remains incompletely understood
-
Aldehyde metabolism governs resilience of mucociliary clearance to air pollution exposure. J. Clin. Invest. (IF 13.3) Pub Date : 2025-05-15
Noriko Shinjyo,Haruna Kimura,Tomomi Yoshihara,Jun Suzuki,Masaya Yamaguchi,Shigetada Kawabata,Yasutaka OkabeAir pollution is a serious environmental threat to public health; however, the molecular basis underlying its detrimental effects on respiratory fitness remains poorly understood. Here, we show that exposure to particulate matter ≤2.5 µm (PM2.5), a significant fraction of air pollutants, induces the generation of reactive aldehyde species in the airway. We identified aldehyde dehydrogenase 1A1 (ALDH1A1)
-
Autophagy is an upstream mediator of chromatin dynamics in normal and autoimmune germinal centre B cells. J. Clin. Invest. (IF 13.3) Pub Date : 2025-05-15
Marta C Sallan,Filip Filipsky,Christina H Shi,Elena Pontarini,Manuela Terranova-Barberio,Gordon Beattie,Andrew Clear,Michele Bombardieri,Kevin Y Yip,Dinis Parente Calado,Mark S Cragg,Sonya James,Matthew J Carter,Jessica Okosun,John G Gribben,Tanya Klymenko,Andrejs BraunGerminal centre (GC) B cells are pivotal in establishing a robust humoral immune response and long-term serological immunity while maintaining antibody self-tolerance. GC B cells rely on autophagy for antigen presentation and homeostatic maintenance. However, these functions, primarily associated with the light zone, cannot explain the spatiotemporal autophagy upregulation in the dark zone of GCs.
-
The gut microbiome controls reactive astrocytosis during Aβ amyloidosis via propionate-mediated regulation of IL-17. J. Clin. Invest. (IF 13.3) Pub Date : 2025-05-13
Sidhanth Chandra,Jelena Popovic,Naveen K Singhal,Elyse A Watkins,Hemraj B Dodiya,Ian Q Weigle,Miranda A Salvo,Abhirami Ramakrishnan,Zhangying Chen,James T Watson,Aashutosh Shetti,Natalie Piehl,Xiaoqiong Zhang,Leah K Cuddy,Katherine R Sadleir,Steven J Schwulst,Murali Prakriya,David Gate,Sangram S Sisodia,Robert VassarAccumulating evidence implicates the gut microbiome (GMB) in the pathogenesis and progression of Alzheimer's disease (AD). We recently showed that the GMB regulates reactive astrocytosis and Aβ plaque accumulation in male APPPS1-21 AD model mice. Yet, the mechanism(s) by which GMB perturbation alters reactive astrocytosis in a manner that reduces Aβ deposition remain unknown. Here, we performed metabolomics
-
Activation of intestinal endogenous retroviruses by alcohol exacerbates liver disease. J. Clin. Invest. (IF 13.3) Pub Date : 2025-05-13
Noemí Cabré,Marcos F Fondevila,Wenchao Wei,Tomoo Yamazaki,Fernanda Raya Tonetti,Alvaro Eguileor,Ricard Garcia-Carbonell,Abraham S Meijnikman,Yukiko Miyamoto,Susan Mayo,Yanhan Wang,Xinlian Zhang,Thorsten Trimbuch,Seija Lehnardt,Lars Eckmann,Derrick E Fouts,Cristina Llorente,Hidekazu Tsukamoto,Peter Stärkel,Bernd SchnablAlcohol-associated liver disease represents a significant global health challenge, with gut microbial dysbiosis and bacterial translocation playing a critical role in its pathogenesis. Patients with alcohol-associated hepatitis had increased fecal abundance of mammalian viruses including retroviruses. This study investigated the role of endogenous retroviruses (ERVs) in the development of alcohol-associated
-
Chromosomal Rearrangements in 1,787 Cases of Acute Leukemia in Korea over 15 years. Ann. Lab. Med. (IF 4.0) Pub Date : 2025-05-12
DongGeun Son,Ho Cheol Jang,Young Eun Lee,Yong Jun Choi,Joo Heon Park,Ha Jin Lim,Hyun-Jung Choi,Hee Jo Baek,Hoon Kook,Mihee Kim,Ga-Young Song,Seo-Yeon Ahn,Sung-Hoon Jung,Deok-Hwan Yang,Je-Jung Lee,Hyeonug-Joon Kim,Jae-Sook Ahn,Myung-Geun ShinBackground Chromosomal alterations serve as diagnostic and prognostic markers in acute leukemia. Given the evolving landscape of chromosomal abnormalities in acute leukemia, we previously studied these over two periods. In this study, we investigated the frequency of these abnormalities and clinical trends in acute leukemia in Korea across three time periods. Methods We retrospectively analyzed data
-
Diagnostic Performance of Eight Blood-based Biomarkers in a Well-characterized Korean Cohort of Preclinical Alzheimer's Disease. Ann. Lab. Med. (IF 4.0) Pub Date : 2025-05-12
Hyojin Chae,Hyejeong Kim,Yoon-Joo Kim,HyunYoung Ji,Eun-Jee Oh,Dong Won YangBackground With the introduction of disease-modifying treatments for Alzheimer's disease (AD), less invasive and widely accessible screening tests are urgently needed. We assessed eight blood-based biomarkers in a well-defined cohort of preclinical AD, including participants with subjective cognitive decline (SCD) and mild cognitive impairment (MCI). Methods Amyloid beta (Aβ) oligomerization tendency
-
SARM1 loss protects retinal ganglion cells in a mouse model of Autosomal Dominant Optic Atrophy. J. Clin. Invest. (IF 13.3) Pub Date : 2025-05-09
Chen Ding,Papa S Ndiaye,Sydney R Campbell,Michelle Y Fry,Jincheng Gong,Sophia R Wienbar,Whitney Gibbs,Philippe Morquette,Luke H Chao,Michael Tri H Do,Thomas SchwarzAutosomal Dominant Optic Atrophy (ADOA), the most prevalent hereditary optic neuropathy, leads to retinal ganglion cell (RGC) degeneration and vision loss. ADOA is primarily caused by mutations in the OPA1 gene, which encodes a conserved GTPase important for mitochondrial inner membrane dynamics. To date, the disease mechanism remains unclear, and no therapies are available. We generated a mouse model
-
NK cell activation and CD4 T cell α4β7 expression are associated with susceptibility to HIV-1. J. Clin. Invest. (IF 13.3) Pub Date : 2025-05-08
Kawthar Machmach,Kombo F N'guessan,Rohit Farmer,Sucheta Godbole,Dohoon Kim,Lauren McCormick,Noemia S Lima,Amy R Henry,Farida Laboune,Isabella Swafford,Sydney K Mika,Bonnie M Slike,Jeffrey R Currier,Leigh Anne Eller,Julie A Ake,Sandhya Vasan,Merlin L Robb,Shelly J Krebs,Daniel C Douek,Dominic Paquin-ProulxWe leveraged specimens from the RV217 prospective study that enrolled participants at high risk of HIV-1 acquisition to investigate how NK, conventional T cells, and unconventional T cells influence HIV-1 acquisition. We observed low levels of α4β7 expression on memory CD4 T cells and iNKT cells, two cell types highly susceptible to HIV-1 infection, in highly exposed seronegative (HESN) compared to